AstraZeneca, Merck cancer treatment attains meaningful improvement in progression-free survival

AstraZeneca Plc and Merck & Co Inc said on Monday their drug to treat a form of ovarian cancer improved progression-free survival in patients tested in a late-stage study.

from Reuters: Health News https://ift.tt/2nPZpq4